Hanall Biopharma Co (XKRX:009420) Dividends per Share : ₩0.00 (TTM As of Dec. 2024)

View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co Dividends per Share?

Hanall Biopharma Co's dividends per share for the three months ended in Dec. 2024 was ₩0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0.00. Its Dividend Payout Ratio for the three months ended in Dec. 2024 was 0.00. As of today, Hanall Biopharma Co's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Hanall Biopharma Co Dividends per Share Historical Data

The historical data trend for Hanall Biopharma Co's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co Dividends per Share Chart

Hanall Biopharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dividends per Share

Get a 7-Day Free Trial

Hanall Biopharma Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Hanall Biopharma Co's Dividends per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Hanall Biopharma Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hanall Biopharma Co's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hanall Biopharma Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Hanall Biopharma Co's Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Hanall Biopharma Co Dividends per Share Calculation

Dividends paid to per common share.

Hanall Biopharma Co (XKRX:009420) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Hanall Biopharma Co's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2024 )	/	EPS without NRI (Q: Dec. 2024 )
	=	0	/	34.32
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Hanall Biopharma Co Dividends per Share Related Terms

Thank you for viewing the detailed overview of Hanall Biopharma Co's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Hanall Biopharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » Dividends per Share

Traded in Other Exchanges

N/A

Address

12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR

Website

http://www.hanall.co.kr

Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co Headlines

No Headlines